| scholarly article | Q13442814 |
| P50 | author | D Allan Butterfield | Q66912067 |
| Raffaella Coccia | Q42761307 | ||
| P2093 | author name string | Marzia Perluigi | |
| P2860 | cites work | The cholinergic hypothesis of Alzheimer's disease: a review of progress | Q22242019 |
| Interactions between fatty acids and alpha-synuclein | Q24336967 | ||
| Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse | Q28144738 | ||
| The hunt for huntingtin function: interaction partners tell many different stories | Q28203006 | ||
| From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS | Q28206361 | ||
| Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease | Q28214290 | ||
| Role of the PLA2-independent peroxiredoxin VI activity in the survival of immortalized fibroblasts exposed to cytotoxic oxidative stress | Q28240398 | ||
| Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease | Q28240604 | ||
| Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes | Q28241500 | ||
| Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice | Q28251779 | ||
| Human carbonyl reductase (CBR) localized to band 21q22.1 by high-resolution fluorescence in situ hybridization displays gene dosage effects in trisomy 21 cells | Q28266041 | ||
| Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33 | Q28295382 | ||
| Oxidative stress and protein oxidation in the brain of water drinking and alcohol drinking rats administered the HIV envelope protein, gp120 | Q28565475 | ||
| Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid | Q61193613 | ||
| Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal | Q68592280 | ||
| Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation | Q70277032 | ||
| Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reaction | Q70614534 | ||
| Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis | Q70958165 | ||
| Generation of alpha-hydroxyaldehydic compounds in the course of lipid peroxidation | Q72045995 | ||
| Copper- and zinc-containing superoxide dismutase can act as a superoxide reductase and a superoxide oxidase | Q73004226 | ||
| Down's syndrome is associated with increased 8,12-iso-iPF2alpha-VI levels: evidence for enhanced lipid peroxidation in vivo | Q73192860 | ||
| The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids | Q73263349 | ||
| Oxidation-dependent changes in the stability and permeability of lipid bilayers | Q73565770 | ||
| Impaired proteasome function in Alzheimer's disease | Q73897101 | ||
| Differential efficacy of lipophilic and cytosolic antioxidants on generation of reactive oxygen species by amyloid-beta | Q74736065 | ||
| Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis | Q77499725 | ||
| Inactivation and nitration of human superoxide dismutase (SOD) by fluxes of nitric oxide and superoxide | Q80063793 | ||
| active site modifications of the brain isoform of creatine kinase by 4-hydroxy-2-nonenal correlate with reduced enzyme activity: mapping of modified sites by Fourier transform-ion cyclotron resonance mass spectrometry | Q80791811 | ||
| Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease | Q80794093 | ||
| Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis | Q80931213 | ||
| Mitochondria as the focus of apoptosis research | Q82498593 | ||
| Oxidation chemistry of catecholamines and neuronal degeneration: an update | Q37861824 | ||
| Lipid peroxidation and neurodegenerative disease. | Q37904195 | ||
| Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids | Q37936917 | ||
| Nonepisodic memory deficits in amnestic MCI. | Q38396686 | ||
| The pathological association between Down syndrome and Alzheimer disease | Q39486734 | ||
| New perspectives on Alzheimer's disease | Q39733117 | ||
| Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis | Q39756716 | ||
| Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease | Q40352054 | ||
| Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction | Q40445312 | ||
| Neurochemistry and toxin models in Huntington's disease. | Q40599311 | ||
| Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration | Q40610035 | ||
| Down syndrome. | Q40906980 | ||
| Current challenges and future applications for protein maps and post-translational vector maps in proteome projects | Q40940495 | ||
| Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis | Q40975834 | ||
| The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells | Q40978148 | ||
| Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis | Q41002046 | ||
| Participation of the mitochondrial genome in the differentiation of neuroblastoma cells | Q41106232 | ||
| Gluconeogenesis in the kidney in vivo in fed rats. Circadian change and substrate specificity | Q41621198 | ||
| Free radical oxidation of polyunsaturated lipids: New mechanistic insights and the development of peroxyl radical clocks | Q41956915 | ||
| Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment | Q42170202 | ||
| Effects of 4-hydroxynonenal on isolated hepatocytes. Studies on chemiluminescence response, alkane production and glutathione status | Q42236255 | ||
| Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. | Q42438521 | ||
| Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. | Q42547512 | ||
| Cytoskeletal modifications induced by 4-hydroxynonenal | Q42813652 | ||
| Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis | Q42830531 | ||
| In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP. | Q42920869 | ||
| The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. | Q43681037 | ||
| Oxidative damage is the earliest event in Alzheimer disease | Q43696731 | ||
| Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients | Q43767626 | ||
| Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues | Q43821139 | ||
| Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. | Q44158605 | ||
| Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis | Q44160891 | ||
| Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease | Q44224817 | ||
| Fructose-1,6-bisphosphate preserves intracellular glutathione and protects cortical neurons against oxidative stress | Q44265105 | ||
| Quantitative assessment of cortical synaptic density in Alzheimer's disease. | Q44558369 | ||
| Increased expression of heat shock proteins in rat brain during aging: relationship with mitochondrial function and glutathione redox state. | Q44828846 | ||
| Autoxidative transformation of chiral omega6 hydroxy linoleic and arachidonic acids to chiral 4-hydroxy-2E-nonenal | Q44981774 | ||
| Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro | Q45049696 | ||
| Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products | Q45239582 | ||
| Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease | Q45297228 | ||
| Oxidative stress in Huntington's disease | Q45297267 | ||
| Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis | Q45303990 | ||
| Increased lipid peroxidation in Down's syndrome mouse models. | Q45914918 | ||
| Increased oxidation of certain glycolysis and energy metabolism enzymes in the frontal cortex in Lewy body diseases | Q46315937 | ||
| Mitochondrial abnormalities in Alzheimer brain: mechanistic implications | Q46456103 | ||
| Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease | Q46483089 | ||
| Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease | Q46580300 | ||
| Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species? | Q46715341 | ||
| 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. | Q46748113 | ||
| Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. | Q46792024 | ||
| Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain | Q46812256 | ||
| Synaptic and neuritic alterations during the progression of Alzheimer's disease | Q46842058 | ||
| Modulation of antioxidant gene expression by 4-hydroxynonenal: atheroprotective role of the Nrf2/ARE transcription pathway | Q36722501 | ||
| Mechanisms of disease: DNA repair defects and neurological disease | Q36753339 | ||
| The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness | Q36823526 | ||
| Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease | Q36878250 | ||
| 4-Hydroxynonenal-protein adducts: A reliable biomarker of lipid oxidation in liver diseases. | Q37044814 | ||
| Alzheimer disease and the role of free radicals in the pathogenesis of the disease | Q37090119 | ||
| Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice | Q37100292 | ||
| Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies | Q37255394 | ||
| Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders | Q37366549 | ||
| Classification and basic pathology of Alzheimer disease | Q37453000 | ||
| Synaptic degeneration in Alzheimer's disease | Q37458270 | ||
| Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates | Q37590869 | ||
| Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism | Q37603401 | ||
| Oxidative stress in ALS: key role in motor neuron injury and therapeutic target | Q37647061 | ||
| Role of oxidative stress in the progression of Alzheimer's disease | Q37671458 | ||
| Alpha-synuclein, lipids and Parkinson's disease | Q37767943 | ||
| Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications | Q37832686 | ||
| Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease | Q29012385 | ||
| Oxidative stress in synaptosomal proteins from mutant presenilin-1 knock-in mice: implications for familial Alzheimer's disease. | Q30330445 | ||
| Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease | Q30489145 | ||
| Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. | Q30497215 | ||
| Down syndrome: advances in molecular biology and the neurosciences | Q30641754 | ||
| Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome | Q30789931 | ||
| Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype | Q30842528 | ||
| Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. | Q31101732 | ||
| Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal | Q31132956 | ||
| Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal | Q33207805 | ||
| Understanding the basis for Down syndrome phenotypes | Q33238943 | ||
| The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation | Q33272109 | ||
| Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease | Q33322972 | ||
| Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD. | Q33431516 | ||
| Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia | Q33540916 | ||
| Alzheimer's disease and down syndrome: from meiosis to dementia | Q33691957 | ||
| Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease | Q33712475 | ||
| Aconitase and ATP synthase are targets of malondialdehyde modification and undergo an age-related decrease in activity in mouse heart mitochondria | Q33721616 | ||
| In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's disease | Q33827620 | ||
| Oxidative stress and neural dysfunction in Down syndrome. | Q33833148 | ||
| Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease | Q33857238 | ||
| Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders | Q33901731 | ||
| Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics | Q33912803 | ||
| Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease | Q33915362 | ||
| Invited review: manganese superoxide dismutase in disease | Q33944740 | ||
| The molecular effects of acrolein | Q34019437 | ||
| The structure and function of initiation factors in eukaryotic protein synthesis | Q34114072 | ||
| Carbonyl reductase | Q34129188 | ||
| Identification of new modulators and protein alterations in non-apoptotic programmed cell death | Q34137207 | ||
| Some Cerebral Proteins and Enzyme Systems in Alzheimer's Presenile and Senile Dementia | Q34160060 | ||
| 4-Hydroxynonenal in the pathomechanisms of oxidative stress | Q34235488 | ||
| Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain | Q34268519 | ||
| Genetic factors in the early diagnosis of ALS. | Q34314363 | ||
| Evidence of increased oxidative damage in subjects with mild cognitive impairment. | Q34410726 | ||
| Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes | Q34428049 | ||
| Carnosine and carnosine-related antioxidants: a review | Q34453394 | ||
| Snaring the function of alpha-synuclein | Q34465204 | ||
| Alpha-synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles | Q34541894 | ||
| Familial amyotrophic lateral sclerosis | Q34547620 | ||
| The role of polyunsaturated fatty acids in restoring the aging neuronal membrane | Q34977011 | ||
| Do oxidatively modified proteins cause ALS? | Q34990599 | ||
| Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease. | Q35088324 | ||
| Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease | Q35125001 | ||
| Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice | Q35152150 | ||
| Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling | Q35165733 | ||
| 4-hydroxynonenal and neurodegenerative diseases | Q35189565 | ||
| Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis | Q35195088 | ||
| Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease | Q35572392 | ||
| Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders | Q35602283 | ||
| Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation | Q35613909 | ||
| Down syndrome and beta-amyloid deposition | Q35691339 | ||
| Regulation of senescence by eukaryotic translation initiation factor 5A: implications for plant growth and development | Q35737988 | ||
| Glucose metabolism and insulin receptor signal transduction in Alzheimer disease | Q35749640 | ||
| Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress | Q35763186 | ||
| Reactions of 4-hydroxynonenal with proteins and cellular targets | Q35874119 | ||
| Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats | Q35882893 | ||
| Manipulation of neuronal nitric oxide synthase within the paraventricular nucleus using adenovirus and antisense technology. | Q36190103 | ||
| Recent advances in the biochemistry and clinical relevance of the isoprostane pathway | Q36355416 | ||
| Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease | Q36360616 | ||
| Ageing and neuronal vulnerability | Q36428039 | ||
| Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease | Q36453571 | ||
| Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease | Q36538283 | ||
| Synaptic cysteine sulfhydryl groups as targets of electrophilic neurotoxicants | Q36552795 | ||
| Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus. | Q36568086 | ||
| Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology | Q36607363 | ||
| Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics | Q36620580 | ||
| Oxidative damage in Huntington's disease pathogenesis | Q36620593 | ||
| Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta | Q46977239 | ||
| Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients | Q48100866 | ||
| Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease | Q48139350 | ||
| Vitamin E and other antioxidants in neuroprotection | Q48174383 | ||
| Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. | Q48182788 | ||
| Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease | Q48246445 | ||
| Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain | Q48270937 | ||
| Lipid peroxidation as cause of nigral cell death in Parkinson's disease | Q48299872 | ||
| Alteration of NMDA receptor-mediated synaptic responses in CA1 area of the aged rat hippocampus: contribution of GABAergic and cholinergic deficits | Q48309545 | ||
| Lipid peroxides in the free radical pathophysiology of brain diseases | Q48314499 | ||
| Biomarkers of oxidative stress are significantly elevated in Down syndrome | Q48319644 | ||
| Microtubule-associated protein tau. A component of Alzheimer paired helical filaments | Q48344680 | ||
| Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis | Q48349098 | ||
| Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. | Q48456664 | ||
| Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease. | Q48464666 | ||
| Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. | Q48482673 | ||
| NMDA receptor activation enhances the release of a cholinergic differentiation peptide (HCNP) from hippocampal neurons in vitro. | Q48485343 | ||
| Early glycoxidation damage in brains from Down's syndrome. | Q48512671 | ||
| Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. | Q48540035 | ||
| Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. | Q48584697 | ||
| Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. | Q48589531 | ||
| The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins. | Q48631799 | ||
| Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex. | Q48632716 | ||
| Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. | Q48701871 | ||
| Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis. | Q48858833 | ||
| Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease. | Q48864975 | ||
| Cholinergic deficit in frontal cerebral cortex in Alzheimer's disease is age dependent | Q49131552 | ||
| Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI. | Q51034709 | ||
| α-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome. | Q51875589 | ||
| Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. | Q51974510 | ||
| Neuropathologic substrate of mild cognitive impairment. | Q51985667 | ||
| Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. | Q52011655 | ||
| Mild cognitive impairment: transition between aging and Alzheimer's disease. | Q52026575 | ||
| The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. | Q52535194 | ||
| Origin of 4-hydroxynonenal incubation-induced inhibition of dopamine transporter and Na+/K+ adenosine triphosphate in rat striatal synaptosomes. | Q52537567 | ||
| Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains. | Q52921597 | ||
| Evaluation of urinary biomarkers of oxidative/nitrosative stress in adolescents and adults with Down syndrome. | Q53082667 | ||
| Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies. | Q53186368 | ||
| Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in Down Syndrome: quantitative comparison with Alzheimer dementia. | Q53197318 | ||
| Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation | Q53200632 | ||
| Hippocampal neurons in pre-clinical Alzheimer's disease. | Q53263608 | ||
| Challenging the cholinergic hypothesis in Alzheimer disease. | Q53335112 | ||
| Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease. | Q53748072 | ||
| Consequences of MnSOD interactions with nitric oxide: nitric oxide dismutation and the generation of peroxynitrite and hydrogen peroxide. | Q54450468 | ||
| Multiple evidence for an early age pro-oxidant state in Down Syndrome patients | Q56601690 | ||
| CRMP-2 induces axons in cultured hippocampal neurons | Q57936437 | ||
| Oxidative damage to protein in sporadic motor neuron disease spinal cord | Q59544371 | ||
| P433 | issue | 11 | |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 1590-1609 | |
| P577 | publication date | 2012-02-15 | |
| P1433 | published in | Antioxidants & Redox Signaling | Q4775078 |
| P1476 | title | 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies | |
| P478 | volume | 17 |
| Q26782039 | 4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product |
| Q39017103 | 4-hydroxynonenal-mediated signaling and aging |
| Q33985200 | A role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stress |
| Q27693922 | Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies |
| Q41692999 | Accumulation of electrophilic aldehydes during postovulatory aging of mouse oocytes causes reduced fertility, oxidative stress, and apoptosis |
| Q46756609 | Age-associated oxidative modifications of mitochondrial α-subunit of F1 ATP synthase from mouse skeletal muscles |
| Q58717283 | Aldehyde Dehydrogenase 2 (ALDH2) in Rat Fatty Liver Cold Ischemia Injury |
| Q89964362 | Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review |
| Q36367840 | Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease |
| Q36074438 | Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53 |
| Q39098224 | Bestrophinopathy: An RPE-photoreceptor interface disease |
| Q91870162 | Biogenic Aldehyde-Mediated Mechanisms of Toxicity in Neurodegenerative Disease |
| Q89808090 | Brain iron deposition is linked with cognitive severity in Parkinson's disease |
| Q99629113 | CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease |
| Q30359347 | Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats. |
| Q53174697 | Constitutive expression of CaPLA1 conferred enhanced growth and grain yield in transgenic rice plants. |
| Q61453870 | Curcumin Exerted Neuroprotection against Ozone-Induced Oxidative Damage and Decreased NF-B Activation in Rat Hippocampus and Serum Levels of Inflammatory Cytokines |
| Q92926964 | Development of a Fluorogenic Reactivity Palette for the Study of Nucleophilic Addition Reactions Based on meso-Formyl BODIPY Dyes |
| Q38309763 | Downregulation of microsomal glutathione-S-transferase 1 modulates protective mechanisms in differentiated PC12 cells |
| Q64061304 | Early existence and biochemical evolution characterise acutely synaptotoxic PrPSc |
| Q48353458 | Early involvement of lysosome dysfunction in the degeneration of cerebral cortical neurons caused by the lipid peroxidation product 4-hydroxynonenal |
| Q35811496 | Effects of Resveratrol Supplementation on Oxidative Damage and Lipid Peroxidation Induced by Strenuous Exercise in Rats |
| Q26995265 | Evidence in support of potential applications of lipid peroxidation products in cancer treatment |
| Q54278299 | Evidence of Oxidative Injury in Pigs With Melanosis Coli. |
| Q37394472 | Gsta4 Null Mouse Embryonic Fibroblasts Exhibit Enhanced Sensitivity to Oxidants: Role of 4-Hydroxynonenal in Oxidant Toxicity |
| Q39006663 | HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology |
| Q47800028 | Heat Shock Protein A2 (HSPA2): Regulatory Roles in Germ Cell Development and Sperm Function. |
| Q33638710 | Inhibition of glycolysis attenuates 4-hydroxynonenal-dependent autophagy and exacerbates apoptosis in differentiated SH-SY5Y neuroblastoma cells |
| Q28391762 | Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease |
| Q38050263 | Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain |
| Q33790988 | Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal |
| Q33862472 | Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans. |
| Q92619543 | Metformin Protects against Oxidative Stress Injury Induced by Ischemia/Reperfusion via Regulation of the lncRNA-H19/miR-148a-3p/Rock2 Axis |
| Q91619653 | Mitochondrial Dysfunction and Changes in High-Energy Compounds in Different Cellular Models Associated to Hypoxia: Implication to Schizophrenia |
| Q34392320 | New covalent modifications of phosphatidylethanolamine by alkanals: mass spectrometry based structural characterization and biological effects |
| Q26828757 | On the role of 4-hydroxynonenal in health and disease |
| Q60907100 | Oxidative Stress in Poultry: Lessons from the Viral Infections |
| Q90577450 | Oxidative stress in microbes after exposure to iron nanoparticles: analysis of aldehydes as oxidative damage products of lipids and proteins |
| Q64269651 | Oxidized unsaturated fatty acids induce apoptotic cell death in cultured cells |
| Q38165872 | Pathophysiology of tobacco smoke exposure: recent insights from comparative and redox proteomics |
| Q34799626 | Probing lipid-protein adduction with alkynyl surrogates: application to Smith-Lemli-Opitz syndrome. |
| Q48184818 | Protective Effect of Meretrix meretrix Oligopeptides on High-Fat-Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice |
| Q38151609 | Protein carbonylation: proteomics, specificity and relevance to aging. |
| Q28392711 | Protein modifications by electrophilic lipoxidation products: adduct formation, chemical strategies and tandem mass spectrometry for their detection and identification |
| Q38727032 | Proteolytic degradation of heat shock protein A2 occurs in response to oxidative stress in male germ cells of the mouse |
| Q30424520 | Reactive intermediates: molecular and MS-based approaches to assess the functional significance of chemical-protein adducts |
| Q40578775 | Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment |
| Q46966345 | Redox proteomics: from protein modifications to cellular dysfunction and disease |
| Q38610212 | Regulation of autophagy, mitochondrial dynamics and cellular bioenergetics by 4-hydroxynonenal in primary neurons |
| Q38090568 | Role of oxidative stress in infectious diseases. A review. |
| Q38162657 | Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets. |
| Q48250772 | Structure Annotation and Quantification of Wheat Seed Oxidized Lipids by High-Resolution LC-MS/MS. |
| Q38647864 | Study on Analysis of Peripheral Biomarkers for Alzheimer's Disease Diagnosis |
| Q41540793 | Subnormothermic Perfusion in the Isolated Rat Liver Preserves the Antioxidant Glutathione and Enhances the Function of the Ubiquitin Proteasome System |
| Q36539464 | Succination is Increased on Select Proteins in the Brainstem of the NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) Knockout Mouse, a Model of Leigh Syndrome |
| Q46667234 | Testosterone depletion increases the susceptibility of brain tissue to oxidative damage in a restraint stress mouse model |
| Q26827320 | The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment |
| Q40566743 | The impact of oxidative stress on chaperone-mediated human sperm-egg interaction. |
| Q30852753 | The role of iron in brain ageing and neurodegenerative disorders. |
| Q46418471 | Thiamine deficiency induces endoplasmic reticulum stress and oxidative stress in human neurons derived from induced pluripotent stem cells |
| Q48642940 | Tibolone prevents oxidation and ameliorates cholinergic deficit induced by ozone exposure in the male rat hippocampus. |
| Q36332494 | Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant |
Search more.